Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell
Clinical trial NCT06441344 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06441344
- Sponsor
- Taizhou Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2026-05-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.